Impaired Coronary Vasodilator Reserve and Adverse Prognosis in Patients With Systemic Inflammatory Disorders
Author(s) -
Brittany Weber,
Emma Stevens,
Lourdes M. Pérez-Chada,
Jenifer M. Brown,
Sanjay Divakaran,
Camden P. Bay,
Courtney Bibbo,
Jon Hainer,
Sharmila Dorbala,
Ron Blankstein,
Viviany R. Taqueti,
Joseph F. Merola,
Elena Massarotti,
Karen H. Costenbader,
Katherine P. Liao,
Marcelo F. Di Carli
Publication year - 2021
Publication title -
jacc. cardiovascular imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.79
H-Index - 120
eISSN - 1936-878X
pISSN - 1876-7591
DOI - 10.1016/j.jcmg.2020.12.031
Subject(s) - medicine , coronary vasodilator , cardiology , systemic inflammation , vasodilation , systemic inflammatory response syndrome , inflammation , sepsis
The purpose of this study was to evaluate the prognostic value of quantitative myocardial blood flow (MBF) and myocardial flow reserve (MFR), reflecting the integrated effects of diffuse atherosclerosis and microvascular dysfunction in patients with systemic inflammatory disorders.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom